Pyogenic granuloma, an impaired wound healing process, linked to vascular growth driven by FLT4 and the nitric oxide pathway

Modern Pathology

Volumn 26, Issue 2, 2013, Pages 247-255

  Godfraind, Catherine ^a   Calicchio, Monica L ^b   Kozakewich, Harry ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

FLT4; gene profiling; lobular capillary hemangioma; nitric oxide pathway; pyogenic granuloma

Indexed keywords

NITRIC OXIDE; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC DATABASE; HEMANGIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; INVOLUTIVE HEMANGIOMA; LASER CAPTURE MICRODISSECTION; LEUKOCYTE; MONOCYTE; PLACENTA; PRIORITY JOURNAL; PROLIFERATIVE HEMANGIOMA; PROTEIN FUNCTION; PYOGENIC GRANULOMA; SERIAL ANALYSIS OF GENE EXPRESSION DATABASE; SIGNAL TRANSDUCTION; TISSUE SECTION; WOUND HEALING IMPAIRMENT;

CAPILLARIES; FEMALE; GENE EXPRESSION; GRANULOMA, PYOGENIC; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; PLACENTA; PREGNANCY; SIGNAL TRANSDUCTION; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; WOUND HEALING;

EID: 84873409582     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.148     Document Type: Article

References (55)

1. Virchow R. Angiome, In: Die krankhaften Geschwülste. August Hirschwald: Berlin, 1863, vol 3, pp306.
2. Mulliken JB, Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg 1982;70:120-121.
3. Boon LM, Ballieux F, Vikkula M. Pathogenesis of vascular anomalies. Clin Plast Surg 2011;38:7-19.
4. Calicchio ML, Collins T, Kozakewich HP. Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide tran-scriptional profiling. Am J Pathol 2009;174:1638-1649.
5. Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003;34:374-378.
6. Patrice SJ, Wiss K, Mulliken JB. Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol 1991;8:267-276.
7. Abaalkhail F, Castonguay M, Driman DK, et al. Lobular capillary hemangioma of the liver. Hepatobiliary Pancreat Dis Int 2009;8:323-325.
8. Abe M, Misago N, Tanaka S, et al. Capillary heman-gioma of the central nervous system: a comparative study with lobular capillary hemangioma of the skin. Acta Neuropathol 2005;109:151-158.
9. Cooper PH, McAllister HA, Helwig EB. Intravenous pyogenic granuloma. A study of 18 cases. Am J Surg Pathol 1979;3:221-228.
10. Hung CH, Kuo HW, Chiu YK, et al. Intravascular pyogenic granuloma arising in an acquired arteriove-nous malformation: report of a case and review of the literature. Dermatol Surg 2004;30:1050-1053.
11. Chen D, Hu XJ, Lin XX, et al. Nodules arising within port-wine stains: a clinicopathologic study of 31 cases. Am J Dermatopathol 2011;33:144-151.
12. Henry F, Quatresooz P, Valverde-Lopez JC, et al. Blood vessel changes during pregnancy: a review. Am J Clin Dermatol 2006;7:65-69.
13. Lin RL, Janniger CK. Pyogenic granuloma. Cutis 2004;74:229-233.
14. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile heman-giomas and human placenta. Arch Dermatol 2001;137: 559-570.
15. Barnes CM, Huang S, Kaipainen A, et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci USA 2005;102: 19097-19102.
16. Jackson JK, Gleave ME, Gleave J, et al. The inhibition of angiogenesis by antisense oligonucleotides to clusterin. Angiogenesis 2005;8:229-238.
17. Lin SY, Craythorn RG, O'Connor AE, et al. Female infertility and disrupted angiogenesis are actions of specific follistatin isoforms. Mol Endocrinol 2008;22: 415-429.
18. Fowden AL, Sibley C, Reik W, et al. Imprinted genes, placental development and fetal growth. Horm Res 2006;65(Suppl 3):50-58.
19. Glazov EA, McWilliam S, Barris WC, et al. Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals. Mol Biol Evol 2008;25:939-948.
20. Frost JM, Moore GE. The importance of imprinting in the human placenta. PLoS Genet 2010;6:e1001015.
21. Liu L, Luo GZ, Yang W, et al. Activation of the imprinted Dlk1-Dio3 region correlates with pluripo-tency levels of mouse stem cells. J Biol Chem 2010;285:19483-19490.
22. Gardiner E, Beveridge NJ, Wu JQ, et al. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Mol Psychiatry 2011;17:827-840.
23. Luk JM, Burchard J, Zhang C, et al. DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem 2011; 286:30706-30713.
24. Kagami M, Sekita Y, Nishimura G, et al. Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat Genet 2008;40:237-242.
25. Castorina A, Giunta S, Mazzone V, et al. Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells. Pep-tides 2010;31:2276-2283.
26. Amano H, Hayashi I, Endo H, et al. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angio-genesis and tumor growth. J Exp Med 2003;197:221-232.
27. Wu JK, Adepoju O, De Silva D, et al. A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma. Angiogenesis 2010;13:15-23.
28. Tammela T, Zarkada G, Wallgard E, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008;454:656-660.
29. Bahram F, Claesson-Welsh L. VEGF-mediated signal transduction in lymphatic endothelial cells. Patho-physiology 2010;17:253-261.
30. Zhang L, Zhou F, Han W, et al. VEGFR-3 ligand-binding and kinase activity are required for lymphan-giogenesis but not for angiogenesis. Cell Res 2010;20: 1319-1331.
31. Walter JW, North PE, Waner M, et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 2002;33:295-303.
32. Matsubara A, Iwama A, Yamazaki S, et al. Endomucin, a CD34-like sialomucin, marks hematopoietic stem cells throughout development. J Exp Med 2005;202: 1483-1492.
33. Hara T, Nakano Y, Tanaka M, et al. Identification of podocalyxin-like protein 1as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region. Immunity 1999;11:567-578.
34. Ciriza J, Garcia-Ojeda ME. Expression of migration-related genes is progressively upregulated in murine Lineage-Sca-1 + c-Kit + population from the fetal to adult stages of development. Stem Cell Res Ther 2010;1:14.
35. Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis 2009;12:197-207.
36. Candinas D, Koyamada N, Miyatake T, et al. Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions. Thromb Haemost 1996;76:807-812.
37. Liesmaa I, Leskinen HK, Kokkonen JO, et al. Hypoxia-induced expression of bradykinin type-2 receptors in endothelial cells triggers NO production, cell migration, and angiogenesis. J Cell Physiol 2009;221: 359-366.
38. Zeng R, Chen YC, Zeng Z, et al. Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells. Heart Vessels 2011; 26:69-80.
39. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclamp-sia. Nat Med 2006;12:642-649.
40. Luque Contreras D, Vargas Robles H, Romo E, et al. The role of nitric oxide in the post-ischemic revasculariza-tion process. Pharmacol Ther 2006;112:553-563.
41. Mendoza MG, Robles HV, Romo E, et al. Nitric oxide-dependent neovascularization role in the lower extremity disease. Curr Pharm Des 2007;13:3591-3596.
42. Alef MJ, Vallabhaneni R, Carchman E, et al. Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats. J Clin Invest 2011;121: 1646-1656.
43. Kibbe M, Billiar T, Tzeng E. Inducible nitric oxide synthase and vascular injury. Cardiovasc Res 1999; 43:650-657.
44. Thom SR, Fisher D, Xu YA, et al. Role of nitric oxide-derived oxidants in vascular injury from carbon monoxide in the rat. Am J Physiol 1999;276:H984-H992.
45. Chachisvilis M, Zhang YL, Frangos JA. G proteincoupled receptors sense fluid shear stress in endothelial cells. Proc Natl Acad Sci USA 2006;103:15463-15468.
46. Plendl J, Snyman C, Naidoo S, et al. Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells. Biol Chem 2000;381: 1103-1115.
47. Ikeda Y, Hayashi I, Kamoshita E, et al. Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. Cancer Res 2004;64:5178-5185.
48. Behdad A, Sun X, Khalpey Z, et al. Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice. Purinergic Signal 2009;5:335-342.
49. van Laake LW, van den Driesche S, Post S, et al. Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 2006;114:2288-2297.
50. Torsney E, Charlton R, Parums D, et al. Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res 2002;51:464-470.
51. Gracheva EV, Samovilova NN, Golovanova NK, et al. Sialyltransferase activity of human plasma and aortic intima is enhanced in atherosclerosis. Biochem Bio-phys Acta 2002;1586:123-128.
52. Adhikari N, Rusch M, Mariash A, et al. Alterations in heparan sulfate in the vessel in response to vascular injury in the mouse. J Cardiovasc Transl Res 2008;1: 236-240.
53. Zhou Z, Wang J, Cao R, et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res 2004;64:4699-4702.
54. Hansen SL, Myers CA, Charboneau A, et al. HoxD3 accelerates wound healing in diabetic mice. Am J Pathol 2003;163:2421-2431.
55. Keuschnigg J, Henttinen T, Auvinen K, et al. The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood 2009;114:478-484.